245 related articles for article (PubMed ID: 33054205)
1. Identification and Pharmacokinetics of Quinone Reductase 2 Inhibitors after Oral Administration of
Liang X; Hu Y; Li J; Chang AK; Tao X; Li Y; Liu W; Pi K; Yuan J; Jiang Z
J Agric Food Chem; 2020 Oct; 68(43):11975-11986. PubMed ID: 33054205
[No Abstract] [Full Text] [Related]
2. Pharmacokinetic properties of pure xanthones in comparison to a mangosteen fruit extract in rats.
Li L; Han AR; Kinghorn AD; Frye RF; Derendorf H; Butterweck V
Planta Med; 2013 May; 79(8):646-53. PubMed ID: 23673465
[TBL] [Abstract][Full Text] [Related]
3. LC-QTOF-MS analysis of xanthone content in different parts of
Khaw KY; Chong CW; Murugaiyah V
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1433-1441. PubMed ID: 32608273
[TBL] [Abstract][Full Text] [Related]
4. Xanthones with quinone reductase-inducing activity from the fruits of Garcinia mangostana (Mangosteen).
Chin YW; Jung HA; Chai H; Keller WJ; Kinghorn AD
Phytochemistry; 2008 Feb; 69(3):754-8. PubMed ID: 17991497
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic characterization of mangosteen (Garcinia mangostana) fruit extract standardized to α-mangostin in C57BL/6 mice.
Petiwala SM; Li G; Ramaiya A; Kumar A; Gill RK; Saksena S; Johnson JJ
Nutr Res; 2014 Apr; 34(4):336-45. PubMed ID: 24774070
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of α-mangostin in rats after intravenous and oral application.
Li L; Brunner I; Han AR; Hamburger M; Kinghorn AD; Frye R; Butterweck V
Mol Nutr Food Res; 2011 May; 55 Suppl 1():S67-74. PubMed ID: 21254395
[TBL] [Abstract][Full Text] [Related]
7. α-Amylase inhibition of xanthones from Garcinia mangostana pericarps and their possible use for the treatment of diabetes with molecular docking studies.
Ibrahim SRM; Mohamed GA; Khayat MTA; Ahmed S; Abo-Haded H
J Food Biochem; 2019 May; 43(5):e12844. PubMed ID: 31353530
[TBL] [Abstract][Full Text] [Related]
8. Xanthones from the botanical dietary supplement mangosteen (Garcinia mangostana) with aromatase inhibitory activity.
Balunas MJ; Su B; Brueggemeier RW; Kinghorn AD
J Nat Prod; 2008 Jul; 71(7):1161-6. PubMed ID: 18558747
[TBL] [Abstract][Full Text] [Related]
9. Antioxidant xanthones from the pericarp of Garcinia mangostana (Mangosteen).
Jung HA; Su BN; Keller WJ; Mehta RG; Kinghorn AD
J Agric Food Chem; 2006 Mar; 54(6):2077-82. PubMed ID: 16536578
[TBL] [Abstract][Full Text] [Related]
10. The purple mangosteen (Garcinia mangostana): Defining the anticancer potential of selected xanthones.
Nauman MC; Johnson JJ
Pharmacol Res; 2022 Jan; 175():106032. PubMed ID: 34896543
[TBL] [Abstract][Full Text] [Related]
11. Prenylated xanthones from mangosteen as promising cholinesterase inhibitors and their molecular docking studies.
Khaw KY; Choi SB; Tan SC; Wahab HA; Chan KL; Murugaiyah V
Phytomedicine; 2014 Sep; 21(11):1303-9. PubMed ID: 25172794
[TBL] [Abstract][Full Text] [Related]
12. New xanthones and cytotoxic constituents from Garcinia mangostana fruit hulls against human hepatocellular, breast, and colorectal cancer cell lines.
Mohamed GA; Al-Abd AM; El-Halawany AM; Abdallah HM; Ibrahim SRM
J Ethnopharmacol; 2017 Feb; 198():302-312. PubMed ID: 28108382
[TBL] [Abstract][Full Text] [Related]
13. Structure activity relationship of xanthones for inhibition of Cyclin Dependent Kinase 4 from mangosteen (Garcinia mangostana L.).
Vemu B; Nauman MC; Veenstra JP; Johnson JJ
Int J Nutr; 2019; 4(2):38-45. PubMed ID: 31363494
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of CDK2/CyclinE1 by xanthones from the mangosteen (
Nauman MC; Tocmo R; Vemu B; Veenstra JP; Johnson JJ
Nat Prod Res; 2021 Dec; 35(23):5429-5433. PubMed ID: 32691623
[TBL] [Abstract][Full Text] [Related]
15. Validation of LC for the determination of alpha-mangostin in mangosteen peel extract: a tool for quality assessment of Garcinia mangostana L.
Yodhnu S; Sirikatitham A; Wattanapiromsakul C
J Chromatogr Sci; 2009 Mar; 47(3):185-9. PubMed ID: 19298703
[TBL] [Abstract][Full Text] [Related]
16. A Method of Effectively Improved α-Mangostin Bioavailability.
Zhao Y; Tang G; Tang Q; Zhang J; Hou Y; Cai E; Liu S; Lei D; Zhang L; Wang S
Eur J Drug Metab Pharmacokinet; 2016 Oct; 41(5):605-13. PubMed ID: 25990757
[TBL] [Abstract][Full Text] [Related]
17. Single dose oral pharmacokinetic profile of α-mangostin in mice.
Ramaiya A; Li G; Petiwala SM; Johnson JJ
Curr Drug Targets; 2012 Dec; 13(14):1698-704. PubMed ID: 23140281
[TBL] [Abstract][Full Text] [Related]
18. Mangosteen Pericarp and Its Bioactive Xanthones: Potential Therapeutic Value in Alzheimer's Disease, Parkinson's Disease, and Depression with Pharmacokinetic and Safety Profiles.
Do HTT; Cho J
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32867357
[TBL] [Abstract][Full Text] [Related]
19. Alpha-Mangostin-Rich Extracts from Mangosteen Pericarp: Optimization of Green Extraction Protocol and Evaluation of Biological Activity.
Ghasemzadeh A; Jaafar HZE; Baghdadi A; Tayebi-Meigooni A
Molecules; 2018 Jul; 23(8):. PubMed ID: 30044450
[TBL] [Abstract][Full Text] [Related]
20. Biological activities and bioavailability of mangosteen xanthones: a critical review of the current evidence.
Gutierrez-Orozco F; Failla ML
Nutrients; 2013 Aug; 5(8):3163-83. PubMed ID: 23945675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
